About NextGen Jane
NextGen Jane is a company based in Oakland (United States) founded in 2014 by Ridhi Tariyal and Stephen Gire. NextGen Jane has raised $19.74 million across 7 funding rounds from investors including Illumina, NIH and HHS. NextGen Jane offers products and services including Menstrual Collection Kit and Health Survey Platform. NextGen Jane operates in a competitive market with competitors including Legacy, Modern Fertility, Fellow, Poplin and MotiveBio, among others.
- Headquarter Oakland, United States
- Founders Ridhi Tariyal, Stephen Gire
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.74 M (USD)
in 7 rounds
-
Latest Funding Round
$7.02 M (USD), Series B
Oct 02, 2023
-
Investors
Illumina
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NextGen Jane
NextGen Jane offers a comprehensive portfolio of products and services, including Menstrual Collection Kit and Health Survey Platform.
Kit for mailing tampons to analyze genomic signals in menstrual blood.
Online survey for gathering demographic and menstrual health information.
People of NextGen Jane
Unlock access to complete
Unlock access to complete
Funding Insights of NextGen Jane
NextGen Jane has successfully raised a total of $19.74M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $7.02 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NextGen Jane
NextGen Jane has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Illumina, NIH and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and holding company controlled by Len Blavatnik
|
Locked | Locked | Locked | |
|
Private investment firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for NextGen Jane
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NextGen Jane
Investment portfolio details for NextGen Jane
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NextGen Jane
Detailed financials for NextGen Jane
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nextgen Jane Comparisons
Peer comparison for NextGen Jane
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NextGen Jane
NextGen Jane operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Legacy, Modern Fertility, Fellow, Poplin and MotiveBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
At-home sperm testing kits and storage services are provided.
|
|
| Locked | Locked | Locked |
Home-based fertility diagnostic kits are offered by Modern Fertility.
|
|
| Locked | Locked | Locked |
Cloud-based suite solutions are provided for enterprise collaboration and management.
|
|
| Locked | Locked | Locked |
Poplin was focused on pre-pregnancy wellness testing services.
|
|
| Locked | Locked | Locked |
Web solutions for personalized fertility diagnostic testing are offered.
|
Detailed competitors of NextGen Jane
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nextgen Jane
Complete news archive for NextGen Jane
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NextGen Jane
NextGen Jane was founded in 2014 and raised its 1st funding round 1 year after it was founded.
NextGen Jane is headquartered in Oakland, United States. It is registered at Oakland, California, United States.
Ridhi Tariyal is the current CEO of NextGen Jane. They have also founded this company.
NextGen Jane is a funded company, having raised a total of $19.74M across 7 funding rounds to date.
NextGen Jane was founded in 2014 in Oakland, United States, within the health diagnostics sector. Direct-to-consumer tests for sexually transmitted diseases are provided to women, offering insights into reproductive health. A genomics-driven approach is employed to monitor biological changes that predict disease onset. Further applications are explored for conditions such as endometriosis, thyroid disorders, metabolic diseases, vitamin deficiencies, and other gynecological issues.
NextGen Jane offers Menstrual Collection Kit and Health Survey Platform.
NextGen Jane has 7 investors. Key investors include Illumina, NIH, HHS, Material Impact, and Access Industries.